tiprankstipranks
Target Healthcare REIT Limited (GB:THRL)
LSE:THRL
UK Market
Want to see GB:THRL full AI Analyst Report?

Target Healthcare REIT (THRL) AI Stock Analysis

42 Followers

Top Page

GB:THRL

Target Healthcare REIT

(LSE:THRL)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
115.00 p
▲(17.47% Upside)
Action:Reiterated
Date:12/11/25
The overall stock score is driven by a solid valuation with a low P/E ratio and high dividend yield, despite concerns over declining cash flow growth and weak technical momentum.
Positive Factors
Recurring rental income from long-term leases
The core business model is owning purpose-built care homes leased under long-term contracts, producing predictable rental income. That recurring, contract-backed cash flow supports dividend sustainability and planning, providing resilience across 2–6 month horizons versus transactional income.
Negative Factors
Declining free cash flow growth
A persistent decline in free cash flow growth constrains the REIT's ability to sustain distributions, fund new acquisitions or invest in property maintenance. Over several months this reduces strategic flexibility and increases sensitivity to earnings or tenant disruptions.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring rental income from long-term leases
The core business model is owning purpose-built care homes leased under long-term contracts, producing predictable rental income. That recurring, contract-backed cash flow supports dividend sustainability and planning, providing resilience across 2–6 month horizons versus transactional income.
Read all positive factors

Target Healthcare REIT (THRL) vs. iShares MSCI United Kingdom ETF (EWC)

Target Healthcare REIT Business Overview & Revenue Model

Company Description
Target Healthcare REIT offers specialized financial solutions, custom-designed to assist operators in expanding the availability of modern, purpose-built residential care facilities throughout the United Kingdom....
How the Company Makes Money
THRL makes money primarily by owning care home real estate and leasing those properties to care home operators under contractual lease agreements. Its core revenue stream is rental income received from tenants, typically structured as long-term le...

Target Healthcare REIT Financial Statement Overview

Summary
Target Healthcare REIT shows stable revenue growth and profitability with a balanced financial structure. However, declining cash flow growth and operational efficiency are concerns.
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue74.61M72.93M78.48M67.75M63.86M49.98M
Gross Profit66.40M64.84M78.48M60.14M56.55M44.18M
EBITDA82.27M59.59M58.00M57.01M50.16M38.85M
Net Income77.93M60.84M73.02M-6.57M49.10M43.88M
Balance Sheet
Total Assets976.51M986.19M967.37M908.26M963.66M718.39M
Cash, Cash Equivalents and Short-Term Investments67.17M39.64M38.88M15.37M34.48M21.11M
Total Debt200.94M240.29M240.67M227.05M231.38M127.90M
Total Liabilities236.22M273.73M278.08M253.45M264.89M153.21M
Stockholders Equity740.28M712.46M689.29M654.81M698.77M565.18M
Cash Flow
Free Cash Flow43.49M41.10M42.34M29.66M30.39M24.96M
Operating Cash Flow43.49M41.10M42.34M29.66M30.39M24.96M
Investing Cash Flow68.08M-3.23M3.42M-3.55M-202.63M-43.58M
Financing Cash Flow-82.31M-37.11M-22.24M-45.23M185.62M3.29M

Target Healthcare REIT Technical Analysis

Technical Analysis Sentiment
Negative
Last Price97.90
Price Trends
50DMA
105.40
Negative
100DMA
103.58
Positive
200DMA
98.28
Positive
Market Momentum
MACD
0.21
Positive
RSI
41.44
Neutral
STOCH
42.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:THRL, the sentiment is Negative. The current price of 97.9 is below the 20-day moving average (MA) of 106.73, below the 50-day MA of 105.40, and below the 200-day MA of 98.28, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 41.44 is Neutral, neither overbought nor oversold. The STOCH value of 42.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:THRL.

Target Healthcare REIT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
£643.81M8.4510.73%6.15%5.45%7.90%
63
Neutral
£2.39B19.896.03%7.30%42.54%117.42%
60
Neutral
£294.31M100.320.80%8.16%5.75%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
£99.55M-10.95-6.64%6.96%-2.03%9.21%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:THRL
Target Healthcare REIT
103.80
6.15
6.30%
GB:PHP
Primary Health Properties plc R.E.I.T
92.20
0.23
0.25%
GB:RESI
Residential Secure Income
53.80
-1.10
-2.00%
GB:HOME
Home REIT PLC
10.00
1.00
11.11%
GB:SOHO
Triple Point Social Housing REIT PLC
74.80
9.38
14.35%

Target Healthcare REIT Corporate Events

Business Operations and StrategyDividendsFinancial Disclosures
Target Healthcare REIT lifts NAV, reinforces balance sheet and ESG-led care home strategy
Positive
May 6, 2026
Target Healthcare REIT reported a 1.0% rise in EPRA Net Tangible Assets per share to 120.6p at 31 March 2026, driven by inflation-linked rent reviews and active asset management, delivering a 2.3% total accounting return for the quarter. The portf...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025